PPH vs RSPH: Differences, Returns & Fees
Over the year to Nov 18, 2026, PPH returned +21.2% to RSPH's +29.7%; 16% of their weight is in the same names.
- Return gap
- +8.5 pts1 year to Nov 18, 2026: RSPH ahead, total return
- Fee gap
- 0.04 ptsA year: PPH 0.36%, RSPH 0.40%, per filings dated Jan 27, 2026 and Aug 27, 2026
- Overlap
- 16%Share of the two books held in common, holdings dated Nov 17, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
PPH +21.2%, RSPH +29.7%: RSPH +8.5 pts ahead, 1 year, Nov 18, 2025 to Nov 18, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in RSPH costs about $3.50 one way and $7.00 in and out, at a median spread of 0.07%. The 0.07% spread is RSPH’s 30-day median, from Invesco (fund page).
Fees over time
Hypothetical. $10,000 in RSPH for 10 years at 0.40% a year costs about $664 in fees and lost growth; PPH at 0.36% would cost $599. Assumes 6% a year before fees, a sample rate, not a forecast.
Key numbers
PPH costs 0.04 points a year less; their one-year returns differ by 8.5 points; PPH is 1.1 times larger.
Pair scorecard
Open the table
| Total return, 1 year | +21.2% | +29.7% |
|---|---|---|
| Below its high | 3.9%, high on Nov 13, 2026 | 4.0%, high on Nov 4, 2026 |
| What it tracks | MVIS US Listed Pharmaceutical 25 Index | S&P 500 Equal Weight Health Care Index |
| Expense ratio | 0.36% | 0.40% |
| Net assets, as of Nov 17, 2026 | $1.1bn | $1.0bn |
| Holdings in common | 16% | |
| Top ten holdings, share of the fund | 71.6% | 19.3% |
The numbers behind it
Net assets on Nov 17, 2026: $1.1bn for VanEck Pharmaceutical ETF and $1.0bn for Invesco S&P 500 Equal Weight Health Care ETF.
Holdings in common uses holdings dated Nov 17, 2026.
What they share
By the books each fund has filed, PPH and RSPH hold 16% of their money in the same securities at the same weight. Holdings dated Nov 17, 2026.
half
16% in common
Held in common
Show all 10 holdings
| Eli Lilly & Co | 23.06% | 1.88% |
| Mckesson Corp | 5.05% | 1.84% |
| Abbvie Inc | 3.70% | 1.75% |
| Zoetis Inc | 2.69% | 1.72% |
| Cencora Inc | 4.47% | 1.63% |
| Viatris Inc | 1.58% | 1.86% |
| Johnson & Johnson | 3.31% | 1.57% |
| Pfizer Inc | 4.69% | 1.56% |
| Merck & Co Inc | 11.97% | 1.46% |
| Bristol-Myers Squibb Co | 4.36% | 1.43% |
Only in PPH
Show all 8 holdings
| Novo Nordisk A/S | 5.48% |
| Teva Pharmaceutical Industries Ltd | 4.66% |
| Gsk Plc | 4.17% |
| Astrazeneca Plc | 3.68% |
| Novartis Ag | 3.67% |
| Sanofi Sa | 3.51% |
| Haleon Plc | 3.38% |
| Takeda Pharmaceutical Co Ltd | 2.94% |
Only in RSPH
Show all 8 holdings
| Moderna Inc | 2.29% |
| IDEXX Laboratories Inc | 2.02% |
| Mettler-Toledo International Inc | 2.00% |
| GE HealthCare Technologies Inc | 1.88% |
| West Pharmaceutical Services Inc | 1.84% |
| Edwards Lifesciences Corp | 1.83% |
| Intuitive Surgical Inc | 1.83% |
| Becton Dickinson & Co | 1.80% |
Side by side
Open the table
| Fund | VanEck Pharmaceutical ETF | Invesco S&P 500 Equal Weight Health Care ETF |
| Where it sits | Stock ETF | Stock ETF |
| Issuer | VanEck | Invesco |
| What it is | Tracks an index | Tracks an index |
| Total return, 1 year | +21.2% | +29.7% |
| Expense ratio | 0.36% | 0.40% |
| Already in the S&P 500 | 64.9% | 100.0% |
| Holdings | 25 | 63 |
| Net assets, as of Nov 17, 2026 | $1.1bn | $1.0bn |
PPH and RSPH on the fields both publish, as of Nov 18, 2026. Source: ETFIQ.
From Nov 2006 to Nov 2026, RSPH returned more: +843.9% to +453.4%. PPH swung slightly less: 17.1% to 18.0%. PPH fell slightly less at its worst: −37.4% to −39.5%.
Full scorecard
Open the table
| Total return | +453.4% | +843.9% | RSPH | Price change plus distributions, reinvested. |
| Annualized | +8.9% | +11.8% | RSPH | Total return as a yearly rate. |
| Price return | +217.2% | +735.3% | RSPH | Price change alone, distributions left out. |
| Volatility | 17.1% | 18.0% | PPH (slight) | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 12.2% | 12.8% | PPH (slight) | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −37.4% | −39.5% | PPH (slight) | Deepest fall from a high to the low after it. |
| Sharpe | 0.49 | 0.62 | RSPH | Return above Treasury bills per unit of volatility. |
| Sortino | 0.69 | 0.87 | RSPH | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.24 | 0.30 | RSPH | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,043 weekly returns. Cash rate: the 13-week Treasury bill.
About PPH
PPH tracks an index. Over the year to Nov 18, 2026 it returned +21.2% with distributions reinvested.
More
The prospectus expense ratio is 0.36% a year. By its holdings published by its issuer for Nov 17, 2026, 65% of the fund by weight is stocks the S&P 500 also holds, across 25 positions, with the top ten at 71.6%. It sat 3.9% below its high of Nov 13, 2026 on Nov 18, 2026.
About RSPH
RSPH tracks an index. Over the year to Nov 18, 2026 it returned +29.7% with distributions reinvested.
More
The prospectus expense ratio is 0.40% a year. By its holdings published by its issuer for Nov 17, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 63 positions, with the top ten at 19.3%. It sat 4.0% below its high of Nov 4, 2026 on Nov 18, 2026.
Questions people ask
Which returned more over the last year, PPH or RSPH?
In the year to Nov 18, 2026, with distributions reinvested, PPH returned +21.2% and RSPH +29.7%.
Which is cheaper, PPH or RSPH?
PPH is cheaper, by 0.04 percentage points a year. That is about $4 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, PPH against RSPH, data as of Nov 18, 2026. https://etfiq.com/compare/any/pph-vs-rsph
ETFIQ. (Nov 18, 2026). PPH against RSPH. Retrieved from https://etfiq.com/compare/any/pph-vs-rsph
[PPH against RSPH (ETFIQ, Nov 18, 2026)](https://etfiq.com/compare/any/pph-vs-rsph)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.